Skip to content
HollisterStier Allergy
HollisterStier Allergy
  • Allergy Immunotherapy
    • Selecting an Allergy Partner
    • Allergy Consulting
    • New Fellows Program
  • Testing
    • ComforTen® Skin Test System
    • QUINTEST® Multiple Skin Test System
    • Histamine Positive Control
    • Intradermal Allergy Extract Preparation
  • Treatments
    • AP Dog
    • Venom
    • Mite Extracts
    • Pollen
      • Cross-Reactivity
    • Other Extracts
    • All Products
  • Resources
  • Ordering
Search:

A Division of Jubilant Pharma

  • About Us
  • News
  • Careers
  • Sales Team
  • Contact Us
Aux Menu
800.495.7437
  • Allergy Immunotherapy
    • Selecting an Allergy Partner
    • Allergy Consulting
    • New Fellows Program
  • Testing
    • ComforTen® Skin Test System
    • QUINTEST® Multiple Skin Test System
    • Histamine Positive Control
    • Intradermal Allergy Extract Preparation
  • Treatments
    • AP Dog
    • Venom
    • Mite Extracts
    • Pollen
      • Cross-Reactivity
    • Other Extracts
    • All Products
  • Resources
  • Ordering

News

AAAAI | ACAAI Venom Extract Shortage Task Force Report

AAAAI | ACAAI Venom Extract Shortage Task Force Report

Industry News, Press ReleaseFebruary 23, 2017

Joint Message Announcing Venom Extract Shortage Task Force Report The AAAAI and ACAAI previously announced a venom extract shortage due to ALK – Abello A/S experiencing a manufacturing delay in regards to its venom products. In response, we formed a task force of experts to generate guidance outlining recommendations for our members which could lead…

Details
12

WARNING Important Safety Information

See full prescribing information for complete boxed warning.

Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

Adverse Reactions

Adverse reactions on our products can be reported by calling 800-495-7437, or by sending us an email. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 800-FDA-1088.

For full prescribing information see our package inserts here

Privacy Policy

Our Privacy Policy has been updated. To give you a better understanding of how we treat your data, please review this Privacy Policy

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Review our use of cookies for more details.

Compliance Program

View our statement of compliance here

Hs Allergy logo on white background

Jubilant HollisterStier Allergy
3525 N Regal Street
Spokane, WA 99207, USA
Tel: +1 509 489 5656

Jubilant Pharma Logo
Jubilant Pharma Holdings Inc.
790 Township Line Road, Suite 175
Yardley, PA 19067, USA
Tel: +1 215 550 2810

Allergy Immunotherapy

Selecting an Allergy Partner
Allergy Consulting
New Fellows Program

Testing

ComforTen Skin Test System
Quintest Multiple Skin Test System
Histamine Positive Control
Intradermal Allergy Extract

Treatments

AP Dog
Venom
Mite Extracts
Pollen
Cross-Reactivity
Other Extracts

Resources

Ordering

About Us

Jubilant Pharma
Vision Values & Promise
Legacy

News

Careers

Sales Team

Contact Us


   
© 2020 HollisterStier Allergy.   A Jubilant Pharma Company.   All Rights Reserved | Jubilant Bhartia Group | Privacy Policy | Compliance Website & Annual Commitment Statement
Go to Top
We use cookies to recognize your repeat visits and preferences, as well as to measure the effectiveness
of campaigns and analyze traffic. If you continue to use this site, we will assume your acceptance.
OK Privacy Policy
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

Warning Message
WARNING Important Safety Information

See full prescribing information for complete boxed warning.

Intended for use only by licensed health care provider experienced in administering allergenic extracts and trained to provide immediate emergency treatment in the event of a life-threatening reaction. Observe patients for at least 30 minutes following administration. Immunotherapy may not be suitable for patients with medical conditions that reduce their ability to withstand a systemic reaction. Allergenic extracts can cause serious systemic reactions, including anaphylactic shock and in rare cases death, especially in patients who have severe or steroid-dependent asthma, cardiovascular disease, or in patients who use beta blockers. Do not inject intravenously. This product is intended for subcutaneous injection for immunotherapy and percutaneous use for diagnosis. Refer to contraindications, warnings, precautions, adverse reaction and over dosage for more detailed information.

Adverse Reactions

Adverse reactions on our products can be reported by calling 800-495-7437, or by emailing us. You are encouraged to report negative side effects of prescription drugs to the FDA. Vist this site, or call 800-FDA-1088.

For full prescribing information see our package inserts here

Privacy Policy

Our Privacy Policy has been updated. To give you a better understanding of how we treat your data, please review this Privacy Policy

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Review our use of cookies for more details.

Compliance Program

View our statement of compliance here